Skip to main content

Gabriel Sampol Rubio

Institutions of which they are part

Pneumology
Vall Hebron Institut de Recerca

Gabriel Sampol Rubio

Institutions of which they are part

Pneumology
Vall Hebron Institut de Recerca

Research lines

Sleep disorders.

The research effort also focuses on the various diagnostic and therapeutic options for respiratory sleep disorders, and, recently, on the vascular repercussions of these disorders. Currently the Group is participating in several multicenter endeavours in non-invasive mechanical ventilation and in a project financed by the FIS to assess the efficacy of treatment with continuous positive air pressure (CPAP) through a nasal route to reduce arterial pressure values in patients with sleep apnoea and arterial hypertension.

IP: Gabriel Sampol Rubio

Projects

Grup de Recerca en Pneumologia

IP: Jaume Ferrer Sancho
Collaborators: Sergi Martí Beltran, Marta Vicenta Arjona Perís, Christian Eduardo Romero Mesones, Maria Angeles Jiménez Fuentes, Mª Jose Jurado Luque, Marc Miravitlles Fernández, Ana Villar Gomez, Antonio Álvarez Fernandez, Victor Monforte Torres, Odile Romero Santo-Tomas, Miriam Barrecheguren Fernández, David Clofent Alarcón, Carles Bravo Masgoret, Mario Culebras Amigo, Fco. Javier Muñoz Gall, Gabriel Sampol Rubio, Maria Antonia Ramon Belmonte, Mercedes Pallero Castillo, Mª Jesús Cruz Carmona, Cristina Berastegui Garcia, Almudena Felipe Montiel, Eva Maria Revilla Lopez, Gerard Orriols Torras, Julia Sampol Sirvent, Meritxell Boada Perez, David Espejo Castellanos, Manuel López Meseguer, David Soler Segovia, Susana Gómez Olles, Berta Saez Gimenez, Iñigo Ojanguren Arranz, Eva Polverino, Letizia Traversi
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 00788
Duration: 01/01/2022 - 30/06/2025

Grup de Recerca de Pneumologia

IP: Jaume Ferrer Sancho
Collaborators: Esther Rodríguez González, Sergi Martí Beltran, Mª Jose Jurado Luque, Marc Miravitlles Fernández, Ana Villar Gomez, Antonio Román Broto, Antonio Álvarez Fernandez, Victor Monforte Torres, Patricia Lloberes Canadell, Javier de Gracia Roldán, Odile Romero Santo-Tomas, Sonia Lopez Rodriguez, Montserrat Murillo Andres, Miriam Barrecheguren Fernández, Carles Bravo Masgoret, Mario Culebras Amigo, Fco. Javier Muñoz Gall, Marta Castro D la Visitación, Gabriel Sampol Rubio, Maria Antonia Ramon Belmonte, Rosa Lloria Verges, Mercedes Pallero Castillo, Mª Jesús Cruz Carmona, Cristina Berastegui Garcia, Manuel López Meseguer, Susana Gómez Olles, Berta Saez Gimenez, Iñigo Ojanguren Arranz, Eva Polverino
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 20000
Reference: 2017SGR0434
Duration: 01/01/2017 - 30/09/2021

Pneumologia (GRC)

IP: Ferran Morell Brotad
Collaborators: Esther Rodríguez González, Sergi Martí Beltran, Mª Jose Jurado Luque, Marc Miravitlles Fernández, Ana Villar Gomez, Antonio Román Broto, Antonio Álvarez Fernandez, Victor Monforte Torres, Patricia Lloberes Canadell, Javier de Gracia Roldán, Odile Romero Santo-Tomas, Sonia Lopez Rodriguez, Montserrat Murillo Andres, Miriam Barrecheguren Fernández, Carles Bravo Masgoret, Mario Culebras Amigo, Fco. Javier Muñoz Gall, Marta Castro D la Visitación, Gabriel Sampol Rubio, Jaume Ferrer Sancho, Maria Antonia Ramon Belmonte, Rosa Lloria Verges, Oriol Roca Gas, Mercedes Pallero Castillo, Mª Jesús Cruz Carmona, Cristina Berastegui Garcia, Manuel López Meseguer, Susana Gómez Olles, Berta Saez Gimenez, Iñigo Ojanguren Arranz
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 523
Duration: 01/01/2014 - 31/12/2016

Estudio de los efectos negativos de la diabetes Mellitus tipo 2 sobre la función pulmonar y la respiración durante el sueño (estudio Sweet Lung)

IP: -
Collaborators: Odile Romero Santo-Tomas, Gabriel Sampol Rubio, Andreea Ciudin Mihai, Olga Mestres Soler
Funding agency: Instituto de Salud Carlos III
Funding: 133705
Reference: PI12/00803
Duration: 01/01/2013 - 31/12/2015

Related news

Vall d'Hebron participated in the study in which more than half of the patients who received treatment with bacteriophages experienced significant improvements

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Pulmonary hypertension is a risk factor for patients who need surgery and, therefore, defining strategies for its management is important to allow a favorable clinical evolution.

Related professionals

Immaculada Creus Gonzalez

Immaculada Creus Gonzalez

Research technician
Read more
Marta Miarons Font

Marta Miarons Font

Head of group
Basic, Translational and Clinical Pharmacy Research
Read more
Alvaro Garcia Tornel Garcia Camba

Alvaro Garcia Tornel Garcia Camba

Senior researcher
Stroke research
Read more
Ferran Polo Torres

Ferran Polo Torres

Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.